E-LIB Suche - Ergebnisse für: Miguel Bergua Burgues, Juan

1

Data-driven flow cytometry classification of blast differen..:

Simoes, Catia ; González, Carmen ; Vergez, François...
Blood Neoplasia. , 2024

Link: https://doi.org/10.1016/..

2

Targeting CD38 by isatuximab and a CD38/CD3xCD28 trispecifi..:

Martin-Sanchez, Esperanza ; Blanco Fernández, Laura ; Kim, Peter S....
Blood Advances. , 2024

Link: https://doi.org/10.1182/..

3

miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab R..:

Cabello, Paula ; Torres-Ruiz, Sandra ; Adam-Artigues, Anna...
Cancers. 15 (2023) 7 - p. 2138 , 2023

Link: https://doi.org/10.3390/..

4

FOVOCIP study: a multicenter randomized trial of fosfomycin..:

Moreno, Ainhoa Fernández ; Lavín-Alconero, Lucía ; de Ugarriza, Paula López...
Trials. 24 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

5

P492: SAFETY AND EFFICACY OF LP-108 AS MONOTHERAPY AND COMB..:

Koenig, Kristin ; Miguel Bergua Burgues, Juan ; Montesinos, Pau...
HemaSphere. 7 (2023) S3 - p. e2546261 , 2023

Link: https://doi.org/10.1097/..

6

AML-522 COVALENT-101: Phase I Study of BMF-219, a Covalent ..:

Ravandi, Farhad ; Lancet, Jeffrey ; Amor, Adrian Alegre...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S310-S311 , 2023

Link: https://doi.org/10.1016/..

7

Clinical outcomes after CPX‐351 in patients with high‐risk ..:

Bernal, Teresa ; Moreno, Ainhoa Fernández ; de LaIglesia, Almudena...
Cancer Medicine. 12 (2023) 14 - p. 14892-14901 , 2023

Link: https://doi.org/10.1002/..

8

POSTER: AML-522 COVALENT-101: Phase I Study of BMF-219, a C..:

Ravandi, Farhad ; Lancet, Jeffrey ; Amor, Adrian Alegre...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S171 , 2023

Link: https://doi.org/10.1016/..

9

P1147: FEASIBILITY AND OUTCOME AFTER DOSE REDUCTION OF IMMU..:

Maria Ribera, Josep ; Morgades, Mireia ; García-Calduch, Olga...
HemaSphere. 7 (2023) S3 - p. e813564b , 2023

Link: https://doi.org/10.1097/..

10

De la precariedad económica a la vulnerabilidad existencial..:

Báez Melián, Juan Miguel ; Bergua Amores, José Angel ; Casas Cortés, Maribel..
Digithum. , 2023

Link: https://doi.org/10.7238/..

11

Safety and efficacy of tafasitamab with or without lenalido..:

Belada, David ; Kopeckova, Katerina ; Bergua Burgues, Juan Miguel...
Blood. 142 (2023) 16 - p. 1348-1358 , 2023

Link: https://doi.org/10.1182/..

12

P531: MIDOSTAURIN PLUS 7 + 3 OR QUIZARTINIB PLUS 7 + 3 IN F..:

Tormo, Mar ; Diaz-Beya, Marina ; Beneit, Paola...
HemaSphere. 7 (2023) S3 - p. e4025574 , 2023

Link: https://doi.org/10.1097/..

13

Integrated flow cytometry and sequencing to reconstruct evo..:

Simoes, Catia ; Chillon, Maria-Carmen ; Martínez-Cuadrón, David...
Blood Advances. 7 (2023) 1 - p. 167-173 , 2023

Link: https://doi.org/10.1182/..

14

P-213 COVALENT-101: phase I study of BMF-219, a covalent me..:

Rosenberg, Aaron ; Baljevic, Muhamed ; Amor, Adrian Alegre...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S152-S153 , 2023

Link: https://doi.org/10.1016/..

15

P498: INCIDENCE, RISK FACTORS AND OUTCOMES OF SECOND NEOPLA..:

Sobas, Marta ; Knopinska-Posluszny, Wanda ; Piątkowska-Jakubas, Beata...
HemaSphere. 7 (2023) S3 - p. e835897e , 2023

Link: https://doi.org/10.1097/..